Orug Disposition

Cion. I'tIarmarol"MI 20 (I): 18-49. 1991 OlI2· ~96J!9 I /OOO I .()(l38/S06.00/O

C Ad"ln!rmahOnal llmllro All nlhls l"C'SCT'Ved. cPlOn~) ndrome a 4·)ear Inlcrnallonal ,'ud, \ hmcn .al) f>harma.-oIOl~ ;lnd Ther.>peullC>: 1.1•.1: 1'188 \1 a,(,,'~hll'l .\J Ito"'ocn C\\ .... cn\on (1. &a,.all (j H. R ~ld J l Thc ~ff''CI; of omel'''''oIc on ~ndocllnc (un,·lIon In man ! urop.-an Journal o((llnl(;l1 Pharmxolog) 3~ J:3·4H. 198' \I , .... ..... R!- \l aC

Clinical pharmacology of omeprazole.

Omeprazole is a specific inhibitor of H+,K(+)-ATPase or 'proton pump' in parietal cells. This enzyme is responsible for the final step in the process ...
3MB Sizes 0 Downloads 0 Views